Indication
Rxulti is indicated for the treatment of schizophrenia in adult and adolescents aged 13 years and older.
In other countries
The same active substances on other registers, the same brand first.
National listings
The national registers that list this EU medicine.
- Rxulti 0,5 MG Comprimidos Recubiertos con PeliculaSpain · 0,5 mgMarketed
- Rxulti 1 MG Comprimidos Recubiertos con PeliculaSpain · 1 mgMarketed
- Rxulti 2 MG Comprimidos Recubiertos con PeliculaSpain · 2 mgMarketed
- Rxulti 3 MG Comprimidos Recubiertos con Pelicula,Spain · 3 mgMarketed
- Rxulti 4 MG Comprimidos Recubiertos con PeliculaSpain · 4 mgMarketed